Cambrex - 32 Year Stock Price History | CBM

Historical daily share price chart and data for Cambrex since 1987 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Cambrex as of February 19, 2019 is 38.34.
Cambrex Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 42.0918 38.6400 46.9400 35.8000 38.3400 1.54%
2018 53.9302 51.5500 68.4000 36.7000 37.7600 -21.33%
2017 53.5488 53.4000 61.9500 42.6500 48.0000 -11.03%
2016 46.0234 44.4100 58.8500 31.1200 53.9500 14.57%
2015 41.5941 21.5800 53.8200 21.3400 47.0900 117.81%
2014 20.5935 17.1000 24.1200 16.2500 21.6200 21.26%
2013 14.1400 11.3700 19.5000 11.2700 17.8300 56.68%
2012 9.2539 7.4000 13.9600 5.9800 11.3800 58.50%
2011 5.2572 5.6300 7.6100 4.0300 7.1800 38.88%
2010 4.3340 5.8300 6.0700 2.9100 5.1700 -7.35%
2009 4.4825 4.3500 7.1700 1.5000 5.5800 20.78%
2008 6.4213 8.7500 10.9600 2.4500 4.6200 -44.87%
2007 11.1908 10.3193 14.3500 7.4400 8.3800 -18.76%
2006 9.5380 8.4785 10.9813 8.3725 10.3147 21.72%
2005 8.9251 11.7655 11.7655 7.6207 8.4740 -30.31%
2004 10.8204 11.1206 12.5447 9.2267 12.1603 7.83%
2003 10.2054 13.3201 13.3201 6.7789 11.2768 -15.93%
2002 16.4170 19.3619 19.6053 10.6895 13.4134 -30.48%
2001 19.5226 19.2259 25.1854 14.8010 19.2955 -3.39%
2000 17.8074 14.6049 21.7897 13.8921 19.9718 31.78%
1999 11.5278 10.5137 15.1549 9.0181 15.1549 44.14%
1998 11.0974 10.4971 12.8526 8.5901 10.5137 4.80%
1997 8.9670 6.9455 11.4385 6.9455 10.0325 41.14%
1996 6.6319 5.7430 7.3951 5.4925 7.1083 21.08%
1995 4.9812 3.8647 6.1167 3.7762 5.8709 60.05%
1994 3.2783 2.7928 3.8156 2.7830 3.6681 29.51%
1993 2.7155 2.3503 2.9600 2.3208 2.8322 20.50%
1992 1.7826 1.1709 2.5470 1.1401 2.3503 97.52%
1991 0.9844 0.5999 1.3571 0.5809 1.1899 104.84%
1990 1.0408 1.6718 1.6816 0.5415 0.5809 -64.63%
1989 1.9327 1.8291 2.2225 1.5734 1.6423 -13.47%
1988 1.9461 2.0553 2.4782 1.4751 1.8980 -4.92%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.266B $0.532B
Cambrex Corporation is an innovative life sciences company with a refreshingly human approach. Driven by passion, their pharmaceutical products, expertise and technologies accelerate customers' small molecule therapeutics into markets across the world. The company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis and controlled substances. Cambrex has transformed from a fine chemical manufacturer to a business with a singular focus on small molecule therapeutics.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $117.200B 13.07
Gilead Sciences (GILD) United States $87.436B 10.97
Biogen (BIIB) United States $65.478B 12.69
Celgene (CELG) United States $63.576B 11.78
Vertex Pharmaceuticals (VRTX) United States $48.081B 64.41
Regeneron Pharmaceuticals (REGN) United States $46.330B 21.52
Illumina (ILMN) United States $44.074B 52.42
Alexion Pharmaceuticals (ALXN) United States $28.921B 17.92
Incyte (INCY) United States $18.013B 168.30
BioMarin Pharmaceutical (BMRN) United States $16.736B 0.00
Seattle Genetics (SGEN) United States $11.477B 0.00
Exact Sciences (EXAS) United States $10.883B 0.00
Sarepta Therapeutics (SRPT) United States $9.252B 0.00
Alnylam Pharmaceuticals (ALNY) United States $8.876B 0.00
QIAGEN (QGEN) Netherlands $8.819B 28.84
BeiGene (BGNE) Cayman Islands $7.856B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.748B 49.54
Bluebird Bio (BLUE) United States $7.495B 0.00
Bio-Techne Corp (TECH) United States $7.237B 48.76
Moderna (MRNA) United States $7.053B 0.00
Exelixis (EXEL) United States $6.655B 15.57
Amarin (AMRN) Ireland $5.703B 0.00
Galapagos (GLPG) Belgium $5.283B 0.00
Alkermes (ALKS) Ireland $5.078B 0.00
Array BioPharma (ARRY) United States $5.047B 0.00
Guardant Health (GH) United States $4.379B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.077B 0.00
Horizon Pharma Public (HZNP) Ireland $3.884B 15.98
Allogene Therapeutics (ALLO) United States $3.795B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.458B 0.00
Emergent Biosolutions (EBS) United States $3.371B 28.40
Blueprint Medicines (BPMC) United States $3.339B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.286B 0.00
Ascendis Pharma (ASND) Denmark $3.087B 0.00
Genomic Health (GHDX) United States $3.011B 101.63
ACADIA Pharmaceuticals (ACAD) United States $2.908B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.865B 0.00
Global Blood Therapeutics (GBT) United States $2.722B 0.00
Immunomedics (IMMU) United States $2.710B 0.00
China Biologic Products (CBPO) China $2.701B 19.23
Repligen (RGEN) United States $2.640B 82.45
Ligand Pharmaceuticals (LGND) United States $2.569B 18.45
Reata Pharmaceuticals (RETA) United States $2.566B 0.00
Mirati Therapeutics (MRTX) United States $2.496B 0.00
Akcea Therapeutics (AKCA) United States $2.472B 0.00
Arena Pharmaceuticals (ARNA) United States $2.466B 0.00
Halozyme Therapeutics (HALO) United States $2.463B 54.97
Myriad Genetics (MYGN) United States $2.305B 23.48
Amicus Therapeutics (FOLD) United States $2.162B 0.00
Insmed (INSM) United States $2.087B 0.00
Spark Therapeutics (ONCE) United States $1.992B 0.00
Denali Therapeutics (DNLI) United States $1.991B 0.00
Acceleron Pharma (XLRN) United States $1.961B 0.00
Atara Biotherapeutics (ATRA) United States $1.846B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.830B 0.00
Medicines (MDCO) United States $1.830B 0.00
AnaptysBio (ANAB) United States $1.828B 0.00
REGENXBIO (RGNX) United States $1.725B 23.14
MyoKardia (MYOK) United States $1.719B 0.00
NeoGenomics (NEO) United States $1.649B 135.69
CRISPR Therapeutics AG (CRSP) Switzerland $1.636B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.630B 0.00
Myovant Sciences (MYOV) United Kingdom $1.509B 0.00
Innoviva (INVA) United States $1.497B 4.13
Allakos (ALLK) United States $1.468B 0.00
Aimmune Therapeutics (AIMT) United States $1.422B 0.00
UniQure (QURE) Netherlands $1.396B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.380B 0.00
ALECTOR INC (ALEC) United States $1.352B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.347B 0.00
Clovis Oncology (CLVS) United States $1.344B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.282B 0.00
Lion Biotechnologies (IOVA) United States $1.272B 0.00
GOSSAMER BIO (GOSS) United States $1.221B 0.00
Codexis (CDXS) United States $1.184B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.172B 0.00
WAVE Life Sciences (WVE) Singapore $1.108B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.107B 44.92
Rubius Therapeutics (RUBY) United States $1.104B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.092B 0.00
Audentes Therapeutics (BOLD) United States $1.055B 0.00
Puma Biotechnology (PBYI) United States $1.055B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.034B 0.00
Epizyme (EPZM) United States $1.020B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.978B 0.00
Editas Medicine (EDIT) United States $0.960B 0.00
Fate Therapeutics (FATE) United States $0.960B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.958B 0.00
Coherus BioSciences (CHRS) United States $0.948B 0.00
Sangamo Therapeutics (SGMO) United States $0.897B 0.00
Retrophin (RTRX) United States $0.889B 0.00
Athenex (ATNX) United States $0.846B 0.00
Vericel (VCEL) United States $0.845B 0.00
CytomX Therapeutics (CTMX) United States $0.829B 0.00
Novavax (NVAX) United States $0.815B 0.00
G1 THERAPEUTICS (GTHX) United States $0.781B 0.00
Apellis Pharmaceuticals (APLS) United States $0.778B 0.00
InflaRx (IFRX) Germany $0.777B 0.00
Arvinas (ARVN) United States $0.770B 0.00
Intra-Cellular Therapies (ITCI) United States $0.765B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.761B 0.00
Heska (HSKA) United States $0.743B 60.84
Cellectis (CLLS) France $0.726B 0.00
Principia Biopharma (PRNB) United States $0.723B 0.00
ANI Pharmaceuticals (ANIP) United States $0.722B 13.81
Dicerna Pharmaceuticals (DRNA) United States $0.718B 0.00
Dynavax Technologies (DVAX) United States $0.698B 0.00
Acorda Therapeutics (ACOR) United States $0.680B 8.83
Cara Therapeutics (CARA) United States $0.670B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.663B 0.00
Revance Therapeutics (RVNC) United States $0.654B 0.00
RA PHARMCTL INC (RARX) United States $0.650B 0.00
Viking Therapeutics (VKTX) United States $0.648B 0.00
Twist Bioscience (TWST) United States $0.643B 0.00
Intellia Therapeutics (NTLA) United States $0.607B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.577B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.567B 0.00
UROGEN PHARMA (URGN) Israel $0.565B 0.00
Kura Oncology (KURA) United States $0.564B 0.00
Eidos Therapeutics (EIDX) United States $0.563B 0.00
Anika Therapeutics (ANIK) United States $0.562B 23.25
Osiris Therapeutics (OSIR) United States $0.550B 0.00
Synthorx (THOR) United States $0.546B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.542B 0.00
Arcus Biosciences (RCUS) United States $0.529B 0.00
Prothena (PRTA) Ireland $0.524B 0.00
Zymeworks (ZYME) Canada $0.502B 0.00
PDL BioPharma (PDLI) United States $0.486B 7.93
UNITY Biotechnology (UBX) $0.476B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.466B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.465B 0.00
Scholar Rock Holding (SRRK) United States $0.462B 0.00
ObsEva SA (OBSV) Switzerland $0.451B 0.00
DBV Technologies (DBVT) France $0.450B 0.00
Zealand Pharma (ZEAL) Denmark $0.450B 4.96
Senesco Technologies (ELOX) United States $0.446B 0.00
Replimune (REPL) United States $0.445B 0.00
Agenus (AGEN) United States $0.433B 0.00
Cytokineticsorporated (CYTK) United States $0.432B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.424B 0.00
Kezar Life Sciences (KZR) United States $0.420B 0.00
Five Prime Therapeutics (FPRX) United States $0.411B 0.00
OSMOTICA PHARM (OSMT) United States $0.406B 0.00
BeyondSpring (BYSI) United States $0.404B 0.00
Mesoblast (MESO) Australia $0.398B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.373B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.369B 0.00
Kindred Biosciences (KIN) United States $0.367B 0.00
Sinovac Biotech (SVA) China $0.367B 0.00
AVROBIO (AVRO) United States $0.367B 0.00
Stemline Therapeutics (STML) United States $0.365B 0.00
Cellular Biomedicine (CBMG) United States $0.360B 0.00
Inovio Pharmaceuticals (INO) United States $0.353B 0.00
MeiraGTx Holdings (MGTX) United States $0.350B 0.00
Gamida Cell (GMDA) Israel $0.339B 0.00
Gritstone Oncology (GRTS) United States $0.337B 0.00
Krystal Biotech (KRYS) United States $0.332B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.330B 0.00
BioDelivery Sciences (BDSI) United States $0.328B 0.00
MediciNova (MNOV) United States $0.322B 0.00
Aduro Biotech (ADRO) United States $0.322B 0.00
Abeona Therapeutics (ABEO) United States $0.318B 0.00
Albireo Pharma (ALBO) United States $0.316B 0.00
Urovant Sciences (UROV) United States $0.314B 0.00
XBiotech (XBIT) United States $0.310B 0.00
Constellation Pharmaceuticals (CNST) United States $0.308B 0.00
Magenta Therapeutics (MGTA) United States $0.306B 0.00
Evelo Biosciences (EVLO) United States $0.293B 0.00
Enochian BioSciences (ENOB) United States $0.287B 0.00
Sorrento Therapeutics (SRNE) United States $0.285B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.283B 0.00
Solid Biosciences (SLDB) United States $0.283B 0.00
Axsome Therapeutics (AXSM) United States $0.278B 0.00
Geron (GERN) United States $0.274B 0.00
Intec Pharma (NTEC) Israel $0.269B 0.00
AC Immune SA (ACIU) Switzerland $0.261B 0.00
Kadmon Holdings (KDMN) United States $0.259B 0.00
Merus (MRUS) Netherlands $0.258B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.254B 0.00
Kodiak Sciences (KOD) United States $0.252B 0.00
Seres Therapeutics (MCRB) United States $0.250B 0.00
Liquidia Technologies (LQDA) United States $0.247B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.247B 0.00
Kala Pharmaceuticals (KALA) United States $0.244B 0.00
Verastem (VSTM) United States $0.244B 0.00
Celcuity (CELC) United States $0.241B 0.00
Adverum Biotechnologies (ADVM) United States $0.240B 0.00
Synlogic (SYBX) United States $0.236B 0.00
Kamada (KMDA) Israel $0.236B 10.64
Paratek Pharmaceuticals (PRTK) United States $0.232B 0.00
MannKind (MNKD) United States $0.231B 0.00
Syros Pharmaceuticals (SYRS) United States $0.231B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.229B 0.00
Sutro Biopharma (STRO) United States $0.225B 0.00
ResTORbio (TORC) United States $0.225B 0.00
Strongbridge Biopharma (SBBP) United States $0.221B 0.00
TOCAGEN INC (TOCA) United States $0.219B 0.00
Athersys (ATHX) United States $0.217B 0.00
Arbutus Biopharma (ABUS) Canada $0.215B 0.00
LogicBio Therapeutics (LOGC) United States $0.209B 0.00
ChromaDex (CDXC) United States $0.208B 0.00
Cerecor (CERC) United States $0.207B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.204B 0.00
Celyad SA (CYAD) Belgium $0.201B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.200B 0.00
ADMA Biologics Inc (ADMA) United States $0.196B 0.00
Aptinyx (APTX) United States $0.189B 0.00
Compugen (CGEN) Israel $0.186B 0.00
Axovant Sciences (AXGT) United Kingdom $0.185B 0.00
Spero Therapeutics (SPRO) United States $0.182B 0.00
Protagonist Therapeutics (PTGX) United States $0.178B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.174B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.166B 0.00
Enzo Biochem (ENZ) United States $0.166B 0.00
Menlo Therapeutics (MNLO) United States $0.164B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.159B 0.00
VBI Vaccines (VBIV) United States $0.157B 0.00
Mersana Therapeutics (MRSN) United States $0.156B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.155B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.151B 0.00
Proteostasis Therapeutics (PTI) United States $0.149B 0.00
OvaScience (MLND) United States $0.145B 0.00
Allena Pharmaceuticals (ALNA) United States $0.143B 0.00
Cohbar (CWBR) United States $0.137B 0.00
BioXcel Therapeutics (BTAI) United States $0.136B 0.00
Cue Biopharma (CUE) United States $0.134B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.133B 0.00
Unum Therapeutics (UMRX) United States $0.129B 0.00
Organovo Holdings (ONVO) United States $0.128B 0.00
Trevena (TRVN) United States $0.127B 0.00
Oncobiologics (OTLK) United States $0.124B 0.00
Fortress Biotech (FBIO) United States $0.124B 0.00
Mustang Bio (MBIO) United States $0.122B 0.00
Anavex Life Sciences (AVXL) United States $0.121B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.121B 0.00
Checkpoint Therapeutics (CKPT) United States $0.121B 0.00
Pluristem Therapeutics (PSTI) Israel $0.119B 0.00
Eton Pharmaceuticals (ETON) United States $0.119B 0.00
XOMA (XOMA) United States $0.118B 0.00
Equillium (EQ) United States $0.113B 0.00
Catalyst Biosciences (CBIO) United States $0.107B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.102B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.100B 0.00
VTv Therapeutics (VTVT) United States $0.097B 0.00
Chiasma (CHMA) United States $0.095B 0.00
Neothetics (EVFM) United States $0.093B 0.00
Signal Genetics (MGEN) United States $0.091B 0.00
NantKwest (NK) United States $0.090B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.082B 0.00
Cocrystal Pharma (COCP) United States $0.079B 88.33
Merrimack Pharmaceuticals (MACK) United States $0.078B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.078B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.078B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.077B 0.00
Orgenesis (ORGS) United States $0.077B 0.00
Alimera Sciences (ALIM) United States $0.076B 0.00
Provention Bio (PRVB) United States $0.075B 0.00
PHASEBIO PHARMA (PHAS) United States $0.074B 0.00
Idera Pharmaceuticals (IDRA) United States $0.072B 0.00
Aptose Biosciences (APTO) Canada $0.072B 0.00
INMUNE BIO INC (INMB) United States $0.070B 0.00
Cidara Therapeutics (CDTX) United States $0.070B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
Celldex Therapeutics (CLDX) United States $0.067B 0.00
SESEN BIO, INC (SESN) United States $0.065B 0.00
AEterna Zentaris (AEZS) United States $0.065B 12.28
Sienna Biopharmaceuticals (SNNA) United States $0.062B 0.00
OVID THERAPEUTC (OVID) United States $0.062B 0.00
Prima BioMed (IMMP) Australia $0.060B 0.00
Applied Genetic Technologies (AGTC) United States $0.059B 0.00
Evogene (EVGN) Israel $0.058B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.058B 0.00
Ophthotech (OPHT) United States $0.058B 0.00
Proteon Therapeutics (PRTO) United States $0.057B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
Vaccinex (VCNX) United States $0.056B 0.00
Eyenovia (EYEN) United States $0.056B 0.00
Entera Bio (ENTX) Israel $0.054B 0.00
VIVUS (VVUS) United States $0.054B 0.00
ScPharmaceuticals (SCPH) United States $0.053B 0.00
ARAVIVE, INC (ARAV) United States $0.053B 4.67
Alcobra (ARCT) United States $0.053B 0.00
Clearside Biomedical (CLSD) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Bellerophon Therapeutics (BLPH) United States $0.048B 0.00
VistaGen Therapeutics (VTGN) United States $0.045B 0.00
Selecta Biosciences (SELB) United States $0.044B 0.00
Bionano Genomics (BNGO) United States $0.042B 0.00
Celsion (CLSN) United States $0.041B 0.00
Caladrius Biosciences (CLBS) United States $0.041B 0.00
OncoSec Medical (ONCS) United States $0.041B 0.00
Moleculin Biotech (MBRX) United States $0.040B 0.00
Motif Bio Plc (MTFB) United States $0.040B 0.00
Arsanis (ASNS) United States $0.039B 0.00
DiaMedica Therapeutics (DMAC) United States $0.038B 0.00
AquaBounty Technologies (AQB) United States $0.038B 0.00
Aptevo Therapeutics (APVO) United States $0.037B 0.00
Leap Therapeutics (LPTX) United States $0.035B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.035B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.034B 5.58
Curis (CRIS) United States $0.034B 0.00
Sophiris Bio (SPHS) United States $0.033B 0.00
Galena Biopharma (SLS) United States $0.031B 0.00
AZURRX BIOPHARM (AZRX) United States $0.031B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.031B 0.00
Adial Pharmaceuticals (ADIL) United States $0.030B 0.00
TRACON Pharmaceuticals (TCON) United States $0.029B 0.00
Aileron Therapeutics (ALRN) United States $0.028B 0.00
IMMURON LTD (IMRN) Australia $0.028B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.028B 0.00
Advaxis (ADXS) United States $0.028B 0.00
Zosano Pharma (ZSAN) United States $0.026B 0.00
Novelion Therapeutics (NVLN) Canada $0.025B 0.00
GENPREX INC (GNPX) United States $0.024B 0.00
Apricus Biosciences (SEEL) United States $0.023B 0.00
GTx (GTXI) United States $0.023B 0.00
Vical (VICL) United States $0.022B 0.00
CytRx (CYTR) United States $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.020B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.020B 0.00
Benitec Biopharma (BNTC) Australia $0.019B 0.00
Gemphire Therapeutics (GEMP) United States $0.016B 0.00
Novogen (KZIA) Australia $0.016B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
ATyr Pharma (LIFE) United States $0.015B 0.00
Soligenix (SNGX) United States $0.015B 0.00
Therapix Biosciences (TRPX) Israel $0.014B 7.25
Prana Biotechnology (PRAN) Australia $0.014B 0.00
Genetic Technologies (GENE) Australia $0.014B 0.00
Aytu Bioscience (AYTU) United States $0.013B 0.00
TrovaGene (TROV) United States $0.013B 0.00
Edge Therapeutics (EDGE) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Alliqua BioMedical (ALQA) United States $0.011B 0.00
Neuralstem (CUR) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
Vital Therapies (VTL) United States $0.009B 0.00
Dare Bioscience (DARE) United States $0.009B 0.00
RestorGenex (DFFN) United States $0.008B 0.00
Histogenics (HSGX) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cellect Biotechnology (APOP) Israel $0.006B 0.00
ARCA Biopharma (ABIO) United States $0.005B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00